Evaxion A EVAX
NASDAQ EVAX
$3.25 +0.07 (+2.19%)
As of: Oct 2, 2026 · 10:39 AM EDT

Evaxion A (EVAX) Interest Income - Net (2021 - 2024)

Updated

Evaxion A (EVAX) recorded Interest Income - Net of $5.63 million in FY2025, compared with -$254,000 in FY2024.

Analysis

Evaxion A (EVAX) Interest Income - Net (2021 - 2024) Analysis & Trends

Starting with FY2018, Evaxion A's Interest Income - Net history includes 8 years.

  • Annual Interest Income - Net has a five-year compound annual growth rate of 96.3% (FY2020 to FY2025).
  • The FY2025 figure is the highest annual Interest Income - Net in data going back to FY2018.
  • Per Business Quant data, EVAX's Interest Income - Net was -$254,000 in FY2024, -$154,000 in FY2023, $1.34 million in FY2022 (+50.1%) and $890,000 in FY2021 (+361.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Income - Net (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Evaxion A 21.02 Mn -45.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -254,000.00
Dec 31, 2023 -154,000.00
Jun 30, 2022 196,000.00
Mar 31, 2022 61,000.00
Mar 31, 2021 295,000.00
API Access

Evaxion A Interest Income - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-income-net&ticker=EVAX&period=max&api_key=YOUR_API_KEY